- Home
- KRMD vs APLT Comparison
KRMD vs APLT Comparison
Compare KRMD & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- APLT
- Stock Information
- Founded
- KRMD 1980
- APLT 2016
- Country
- KRMD United States
- APLT United States
- Employees
- KRMD N/A
- APLT N/A
- Industry
- KRMD Medical/Dental Instruments
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- APLT Health Care
- Exchange
- KRMD Nasdaq
- APLT Nasdaq
- Market Cap
- KRMD 192.3M
- APLT 178.6M
- IPO Year
- KRMD N/A
- APLT 2019
- Fundamental
- Price
- KRMD $3.98
- APLT $1.28
- Analyst Decision
- KRMD Strong Buy
- APLT Buy
- Analyst Count
- KRMD 4
- APLT 5
- Target Price
- KRMD $4.63
- APLT $4.13
- AVG Volume (30 Days)
- KRMD 76.9K
- APLT 5.5M
- Earning Date
- KRMD 11-12-2025
- APLT 11-10-2025
- Dividend Yield
- KRMD N/A
- APLT N/A
- EPS Growth
- KRMD N/A
- APLT N/A
- EPS
- KRMD N/A
- APLT N/A
- Revenue
- KRMD $36,848,451.00
- APLT $121,000.00
- Revenue This Year
- KRMD $21.08
- APLT N/A
- Revenue Next Year
- KRMD $16.37
- APLT $5,935.35
- P/E Ratio
- KRMD N/A
- APLT N/A
- Revenue Growth
- KRMD 19.57
- APLT N/A
- 52 Week Low
- KRMD $1.86
- APLT $0.30
- 52 Week High
- KRMD $5.05
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- KRMD 45.19
- APLT 60.36
- Support Level
- KRMD $3.94
- APLT $1.16
- Resistance Level
- KRMD $4.32
- APLT $1.50
- Average True Range (ATR)
- KRMD 0.16
- APLT 0.14
- MACD
- KRMD -0.02
- APLT -0.02
- Stochastic Oscillator
- KRMD 12.34
- APLT 61.64
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.